Ranitak

indications and dosage

1 - Duodenal and benign gastric ulcers:

Treatment : Oral 150 mg twice daily or soc at bedtime tor at least 4-6 weeks.

Maintenance : Oral 150 mg at bedtime tor more than year it required.

- Gastro - oesophageai reflux :

Treatment : Oral 150 mg twice daily for not more  than 6 weeks.

- Gastric hypersecretory conditions :( e.g. Zollinger - Ellison syndrome, systemic rnastocytosis.

multiple endocrine adenomas ). ‘

-Upper gastrointestinal stress-induced ulceration and bleeding :

Treatment and Prophylaxis : Oral 150 mg twice daily, or parenteral therapy may be used.

- Aspiration syndrome : -

Prophylaxis : Oral 150 mg may be given 2 hours before the induction oi anaesthesia or at the start of labour to reduce the danger oi aspiration of acidic gastric contents and may be repeated_ at intervals of 6 hours if required

side effects/ Aderse effects

' “headache rare hypersensitivity reactions  bradycardia, dizziness, skin rash. transient revereible

' changes in liver functlon teats may occur.

Reversible leuoopserria‘ and tlirombooytopaentt-‘fhave been

Unlike cimeticiihe, Ranitldlne has little or no anti-androgenic etiect and lncldenceot

gynaecothastia and impotence in patients treated with  closes oi Ranitidine has been

reported not to differ from that encountered in the general population.

Precautions :

. The usual dosage should be reduced tor patients with liver impairment. .- it is generally considered that drug interaction is far less in comparison to cimetidine.

- Gastric malignancy must be excluded before therapy with Ranltak.

- Ranitak should only be used during pregnancy and nursing mothers if clearly needed.

keep out oi reach oi children.

Ranitak 150 mg : Box oi 20 tablets or 1000 tablets . _ Q

Ranitak 300 mg Box of 20 tablets.

Produced by ct.

SEDICO Pharmaceutical Co.

6 October City - Egypt